Top 10 Traded US Stocks on POEMS in August 2020 September 16, 2020

Top 10 Traded US Stocks on POEMS in August 2020

In this article, we will look at August’s Top 10 traded U.S. stocks on Phillip’s Online Electronic Mart System (POEMS), based on their gross market value traded. We hope this data will give you an overall macroeconomic view and provide insights on liquidity and consumer trend that affect these popular traded stocks.

We saw three U.S. major indexes: Dow Jones, S&P 500 and Nasdaq Composite continue to rise in the month of August. While Dow Jones Index was approximately 3% away from setting its new all-time high, both S&P 500 and Nasdaq Composite rose beyond 3,500 points and 12,000 mark respectively.

Without further ado, let’s countdown the list starting from the 10th position:

10th: Zoom Video Communications Inc (NASDAQ: ZM)

One of the rising stars amid the COVID-19 pandemic, Zoom Video finally made it to the top 10 list on POEMS. The stock’s price surpassed USD300 and soared more than 40% since its last quarterly earnings report.

Amidst the consistent surge in new COVID-19 cases, the usage of Zoom video remains high and looks set to become a permanent structural change. Investors’ focus will be on the company’s second quarter earnings release (released on 31 Aug) where it justifies whether its rise to stardom is sustainable. The consensus EPS forecast for the quarter is USD0.341.

9th: Alibaba Group Holding Ltd (NASDAQ: BABA)

China’s tech giant fell from its previous 6th spot in July, but still maintained its position as one of the most traded stocks on POEMS. Alibaba’s stock price has been consistently inching high and is now trading at near 52-weeks high level.

The consistent rise in the tech giant’s share price in August could be attributed by the IPO announcement of the much anticipated ANT Financial Group, which is an affiliate of Alibaba. The fintech company is looking to raise a record of USD30 billion shares in its planned IPO2.

This will certainly capture investors’ interest in Alibaba.

8th: Moderna Inc (NASDAQ: MRNA)

One of the forerunners in coming up with COVID-19 vaccine, Moderna has fallen off from its 4th position in July. The company’s share price in August was not encouraging when it plunged to USD64 on 31 August after hitting a record high at USD95 on 17 July.

Though the clinical trials for its COVID-19 vaccine candidate (Mrna-1273) is progressing well, the biotech company’s patents filed are probed by the U.S. Defense Department. The company is alleged to have failed to disclose USD25 million in government funding as required by federal law3.

7th: Sorrento Therapeutics Inc (NASDAQ: SRNE)

Another forerunner of the COVID-19 vaccine, Sorrento Therapeutics improved its standing among the top traded stocks on POEMS to the 7th spot. The biotech company sees the share price hit its record high of USD19.39 on 10 August before retracing back to USD8 level on 31 August.

The fall from its record high share price was mainly due to a controversial report published by Hindenburg Research with regards to the company’s COVID-19 diagnostic products, where it is believed to manipulate negatively on the company’s stock price4. Following that, U.S. Food and Drug Administration (FDA) also announced the emergency use authorisation of SalivaDirect COVID-10 diagnostic test developed by Yale University. This competes directly with Sorrento’s COVI-TRACE.

6th: Facebook Inc (NASDAQ: FB)

Facebook claims its 6th spot on the list in August. With NASDAQ surging to past record level, this tech giant is one of the tech leaders leading the way and trading at record levels. Facebook’s share price broke the USD300 price level on 26 August though it has since fallen to USD295.

The recent operational mistake of Facebook to remove a militia page puts the company in a vulnerable position especially so after the previous hate speech saga from U.S. President Donald Trump resulting in an advertisement boycott. This had happened when two people who were shot and killed during protests, following a white police officer’s shooting that left a black man, Jacob Blake Jr, paralysed. All eyes were on Facebook on its handling of this thorny situation5.

5th: Fastly Inc (NYSE: FSLY)

Fastly, a provider of edge cloud computing and content delivery network (CDN) climbed all the way from 10th spot in July to 5th this month. However, it was a roller coaster ride for Fastly’s share price. After hitting high at USD116 on 5 August, it took a fall to USD73 on 11 August before recovering to about USD94 towards the end of August.

The sink in share price was mainly due to the forward guidance during its earnings announcement where it fall short of lofty hopes. However, the management is still confident of the business growth for the remainder of 2020. On 27 August, Fastly announced its acquisition of Signal Sciences to enhance its cyber security’s solutions offering5.

4th: Apple Inc (NASDAQ: AAPL)

The popular maker of iPhone, Apple, finally made it to the list this month, occupying the 4th position. Its share price surpassed USD500 and is more than double as compared to March.

At the end of July, Apple announced its quarterly result which smashed analysts’ estimates and sent the stock soaring high. On the same day, Apple also announced a forward stock split of 4 for 1, which took effect on 31 August, the same day as Tesla. The shares soared higher and propelle Apple as the first U.S. company to surpass USD2 trillion market cap. In August 2018, Apple was the first U.S. company to hit USD1 trillion6. It only took Apple around two years to double its valuation.

3rd: Microsoft Corporation (NASDAQ: MSFT)

The tech giant took a step back this month but remained on the list’s the top 3. In comparison to other stocks on the list, the price movement of Microsoft is relatively stable in August with only about a fluctuation of +/- 5%.

The trading volume on Microsoft remained high mainly due to the news and rumours around its bidding on TikTok. The popular video application was forced to sell its U.S. business due to the privacy issues raised by the U.S. government. However, the deal remains uncertain as China has recently tightened their tech export rule7.

2nd: NIO Inc (NYSE: NIO)

A rival to Tesla, NIO together with recently listed Li Auto and XPeng, are competing against Tesla in China, the world’s largest electronic vehicle market. NIO climbed up one spot to second this month.

The stock crossed the USD20 mark, up almost 90% on 26 August. However, the share price took a dip upon announcement of its additional offering. NIO announced a secondary offering in August to seek additional funding of around USD1.4 – 1.7 billion8.

1st: Tesla Inc (NASDAQ: TSLA)

The month of August belongs to the electronic vehicle maker and leader, Tesla. Top on the list, its total value traded on POEMS is also higher than the previous month.

On 10 August, Tesla announced a forward split of 5 for 1 with effect on 31 August and the stocks spiked about 70%. In July, Tesla took over Toyota as the world’s largest car maker in term of market capitalisation and today, it is worth more than 2 times of Toyota9.


With so much news going around, investors like you may need some time to digest the above information. Alternatively, you may join our free webinars and listen to our experts who will share their insights on the various investment topics. With the U.S. elections coming soon, do also watch out this space for our new series of U.S. Elections in the coming weeks.

Do you have any trading views on the U.S. elections? Join our global investment community telegram group and share your thoughts with us!



These commentaries are intended for general circulation. It does not have regard to the specific investment objectives, financial situation and particular needs of any person who may receive this document. Accordingly, no warranty whatsoever is given and no liability whatsoever is accepted for any loss arising whether directly or indirectly as a result of any person acting based on this information. Opinions expressed in these commentaries are subject to change without notice. Investments are subject to investment risks including the possible loss of the principal amount invested. The value of the units and the income from them may fall as well as rise. Past performance figures as well as any projection or forecast used in these commentaries are not necessarily indicative of future or likely performance. Phillip Securities Pte Ltd (PSPL), its directors, connected persons or employees may from time to time have an interest in the financial instruments mentioned in these commentaries. Investors may wish to seek advice from a financial adviser before investing. In the event that investors choose not to seek advice from a financial adviser, they should consider whether the investment is suitable for them.

The information contained in these commentaries has been obtained from public sources which PSPL has no reason to believe are unreliable and any analysis, forecasts, projections, expectations and opinions (collectively the “Research”) contained in these commentaries are based on such information and are expressions of belief only. PSPL has not verified this information and no representation or warranty, express or implied, is made that such information or Research is accurate, complete or verified or should be relied upon as such. Any such information or Research contained in these commentaries are subject to change, and PSPL shall not have any responsibility to maintain the information or Research made available or to supply any corrections, updates or releases in connection therewith. In no event will PSPL be liable for any special, indirect, incidental or consequential damages which may be incurred from the use of the information or Research made available, even if it has been advised of the possibility of such damages. The companies and their employees mentioned in these commentaries cannot be held liable for any errors, inaccuracies and/or omissions howsoever caused. Any opinion or advice herein is made on a general basis and is subject to change without notice. The information provided in these commentaries may contain optimistic statements regarding future events or future financial performance of countries, markets or companies. You must make your own financial assessment of the relevance, accuracy and adequacy of the information provided in these commentaries.

Views and any strategies described in these commentaries may not be suitable for all investors. Opinions expressed herein may differ from the opinions expressed by other units of PSPL or its connected persons and associates. Any reference to or discussion of investment products or commodities in these commentaries is purely for illustrative purposes only and must not be construed as a recommendation, an offer or solicitation for the subscription, purchase or sale of the investment products or commodities mentioned.

Contact us to Open an Account

Need Assistance? Share your Details and we’ll get back to you


This material is provided by Phillip Capital Management (S) Ltd (“PCM”) for general information only and does not constitute a recommendation, an offer to sell, or a solicitation of any offer to invest in any of the exchange-traded fund (“ETF”) or the unit trust (“Products”) mentioned herein. It does not have any regard to your specific investment objectives, financial situation and any of your particular needs. You should read the Prospectus and the accompanying Product Highlights Sheet (“PHS”) for key features, key risks and other important information of the Products and obtain advice from a financial adviser (“FA“) pursuant to a separate engagement before making a commitment to invest in the Products. In the event that you choose not to obtain advice from a FA, you should assess whether the Products are suitable for you before proceeding to invest. A copy of the Prospectus and PHS are available from PCM, any of its Participating Dealers (“PDs“) for the ETF, or any of its authorised distributors for the unit trust managed by PCM.  

An ETF is not like a typical unit trust as the units of the ETF (the “Units“) are to be listed and traded like any share on the Singapore Exchange Securities Trading Limited (“SGX-ST”). Listing on the SGX-ST does not guarantee a liquid market for the Units which may be traded at prices above or below its NAV or may be suspended or delisted. Investors may buy or sell the Units on SGX-ST when it is listed. Investors cannot create or redeem Units directly with PCM and have no rights to request PCM to redeem or purchase their Units. Creation and redemption of Units are through PDs if investors are clients of the PDs, who have no obligation to agree to create or redeem Units on behalf of any investor and may impose terms and conditions in connection with such creation or redemption orders. Please refer to the Prospectus of the ETF for more details.  

Investments are subject to investment risks including the possible loss of the principal amount invested. The purchase of a unit in a fund is not the same as placing your money on deposit with a bank or deposit-taking company. There is no guarantee as to the amount of capital invested or return received. The value of the units and the income accruing to the units may fall or rise. Past performance is not necessarily indicative of the future or likely performance of the Products. There can be no assurance that investment objectives will be achieved.  

Where applicable, fund(s) may invest in financial derivatives and/or participate in securities lending and repurchase transactions for the purpose of hedging and/or efficient portfolio management, subject to the relevant regulatory requirements. PCM reserves the discretion to determine if currency exposure should be hedged actively, passively or not at all, in the best interest of the Products.  

The regular dividend distributions, out of either income and/or capital, are not guaranteed and subject to PCM’s discretion. Past payout yields and payments do not represent future payout yields and payments. Such dividend distributions will reduce the available capital for reinvestment and may result in an immediate decrease in the net asset value (“NAV”) of the Products. Please refer to <> for more information in relation to the dividend distributions.  

The information provided herein may be obtained or compiled from public and/or third party sources that PCM has no reason to believe are unreliable. Any opinion or view herein is an expression of belief of the individual author or the indicated source (as applicable) only. PCM makes no representation or warranty that such information is accurate, complete, verified or should be relied upon as such. The information does not constitute, and should not be used as a substitute for tax, legal or investment advice.  

The information herein are not for any person in any jurisdiction or country where such distribution or availability for use would contravene any applicable law or regulation or would subject PCM to any registration or licensing requirement in such jurisdiction or country. The Products is not offered to U.S. Persons. PhillipCapital Group of Companies, including PCM, their affiliates and/or their officers, directors and/or employees may own or have positions in the Products. Any member of the PhillipCapital Group of Companies may have acted upon or used the information, analyses and opinions herein before they have been published. 

This advertisement has not been reviewed by the Monetary Authority of Singapore.  


Phillip Capital Management (S) Ltd (Co. Reg. No. 199905233W)  
250 North Bridge Road #06-00, Raffles City Tower ,Singapore 179101 
Tel: (65) 6230 8133 Fax: (65) 65383066